Erkki Rintala

3.7k total citations · 1 hit paper
41 papers, 2.6k citations indexed

About

Erkki Rintala is a scholar working on Surgery, Molecular Biology and Urology. According to data from OpenAlex, Erkki Rintala has authored 41 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 11 papers in Molecular Biology and 8 papers in Urology. Recurrent topics in Erkki Rintala's work include Bladder and Urothelial Cancer Treatments (37 papers), Urinary and Genital Oncology Studies (32 papers) and Urinary Tract Infections Management (8 papers). Erkki Rintala is often cited by papers focused on Bladder and Urothelial Cancer Treatments (37 papers), Urinary and Genital Oncology Studies (32 papers) and Urinary Tract Infections Management (8 papers). Erkki Rintala collaborates with scholars based in Finland, Sweden and Norway. Erkki Rintala's co-authors include Per‐Uno Malmström, Eero Kaasinen, Pertti Rajala, Amir Sherif, Sten Nilsson, Mika Raitanen, Harri Juusela, Richard Sylvester, Eduardo Solsona and Teuvo L.J. Tammela and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Erkki Rintala

41 papers receiving 2.5k citations

Hit Papers

An Individual Patient Data Meta-Analysis of the Long-Term... 2009 2026 2014 2020 2009 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
    2009 465 citations Per‐Uno Malmström, Richard Sylvester et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erkki Rintala Finland 26 2.2k 813 562 497 473 41 2.6k
Eduardo Solsona Spain 22 2.8k 1.3× 993 1.2× 594 1.1× 545 1.1× 412 0.9× 41 3.2k
A. Masson-Lecomte France 18 1.7k 0.8× 453 0.6× 462 0.8× 463 0.9× 665 1.4× 87 2.2k
Daniel Willis United States 15 1.5k 0.7× 266 0.3× 411 0.7× 527 1.1× 446 0.9× 18 1.8k
Daniele Raggi Italy 26 1.5k 0.7× 234 0.3× 596 1.1× 352 0.7× 540 1.1× 177 2.0k
José L. Domínguez-Escrig Spain 17 1.3k 0.6× 465 0.6× 260 0.5× 250 0.5× 595 1.3× 36 1.8k
Christine de Balincourt Belgium 15 1.1k 0.5× 235 0.3× 468 0.8× 245 0.5× 217 0.5× 23 1.4k
Michael P. Corder United States 16 789 0.4× 157 0.2× 509 0.9× 206 0.4× 231 0.5× 46 1.7k
LaMont Barlow United States 16 488 0.2× 166 0.2× 244 0.4× 420 0.8× 319 0.7× 36 1.0k
Begoña P. Valderrama Spain 16 1.1k 0.5× 112 0.1× 607 1.1× 296 0.6× 356 0.8× 85 1.4k
Peter Jenkins United Kingdom 17 777 0.4× 318 0.4× 386 0.7× 113 0.2× 355 0.8× 31 1.3k

Countries citing papers authored by Erkki Rintala

Since Specialization
Citations

This map shows the geographic impact of Erkki Rintala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkki Rintala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkki Rintala more than expected).

Fields of papers citing papers by Erkki Rintala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkki Rintala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkki Rintala. The network helps show where Erkki Rintala may publish in the future.

Co-authorship network of co-authors of Erkki Rintala

This figure shows the co-authorship network connecting the top 25 collaborators of Erkki Rintala. A scholar is included among the top collaborators of Erkki Rintala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkki Rintala. Erkki Rintala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Järvinen, Riikka, Per M. Hellström, Erkki Rintala, et al.. (2021). Repeated 5-aminolevulinic Acid Instillations During Follow-up in Non-muscle-invasive Bladder Cancer: A Randomized Study. In Vivo. 35(3). 1561–1568. 4 indexed citations
2.
Marttila, Timo, Riikka Järvinen, Tapani Liukkonen, et al.. (2016). Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non–Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study. European Urology. 70(2). 341–347. 25 indexed citations
3.
4.
Rosenblatt, Robert, Amir Sherif, Erkki Rintala, et al.. (2011). Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer. European Urology. 61(6). 1229–1238. 193 indexed citations
5.
Malmström, Per‐Uno, Richard Sylvester, David Crawford, et al.. (2009). An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer. European Urology. 56(2). 247–256. 465 indexed citations breakdown →
6.
7.
Hotakainen, Kristina, Susanna Lintula, Annukka Paju, et al.. (2006). Overexpression of Human Chorionic Gonadotropin β Genes 3, 5 and 8 in Tumor Tissue and Urinary Cells of Bladder Cancer Patients. Tumor Biology. 28(1). 52–56. 27 indexed citations
8.
Meijden, Adrian P.M. van der, Richard Sylvester, Willem Oosterlinck, et al.. (2005). EAU Guidelines on the Diagnosis and Treatment of Urothelial Carcinoma in Situ. European Urology. 48(3). 363–371. 80 indexed citations
9.
Kaasinen, Eero, Hans Wijkström, Per‐Uno Malmström, et al.. (2003). Alternating Mitomycin C and BCG Instillations versus BCG Alone in Treatment of Carcinoma in Situ of the Urinary Bladder: A Nordic Study. European Urology. 43(6). 637–645. 65 indexed citations
10.
Sherif, Amir, Lars Holmberg, Erkki Rintala, et al.. (2003). Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic Studies. European Urology. 45(3). 297–303. 180 indexed citations
11.
Kaasinen, Eero, Erkki Rintala, Per M. Hellström, et al.. (2002). Factors Explaining Recurrence in Patients Undergoing Chemoimmunotherapy Regimens for Frequently Recurring Superficial Bladder Carcinoma. European Urology. 42(2). 167–174. 107 indexed citations
12.
Hotakainen, Kristina, Caj Haglund, Annukka Paju, et al.. (2002). Chorionic Gonadotropin β-Subunit and Core Fragment in Bladder Cancer: mRNA and Protein Expression in Urine, Serum and Tissue. European Urology. 41(6). 677–685. 14 indexed citations
13.
14.
Raitanen, Mika, Risto Aine, Erkki Rintala, et al.. (2002). Differences Between Local and Review Urinary Cytology in Diagnosis of Bladder Cancer. An Interobserver Multicenter Analysis. European Urology. 41(3). 284–289. 169 indexed citations
15.
Raitanen, Mika, Timo Marttila, Eero Kaasinen, et al.. (2000). SENSITIVITY OF HUMAN COMPLEMENT FACTOR H RELATED PROTEIN (BTA STAT) TEST AND VOIDED URINE CYTOLOGY IN THE DIAGNOSIS OF BLADDER CANCER. The Journal of Urology. 1689–1692. 1 indexed citations
16.
Raitanen, Mika, Timo Marttila, Eero Kaasinen, et al.. (2000). SENSITIVITY OF HUMAN COMPLEMENT FACTOR H RELATED PROTEIN (BTA STAT) TEST AND VOIDED URINE CYTOLOGY IN THE DIAGNOSIS OF BLADDER CANCER. The Journal of Urology. 163(6). 1689–1692. 34 indexed citations
17.
Liukkonen, Tapani, Pertti Rajala, Mika Raitanen, et al.. (1999). Prognostic Value of MIB-1 Score, p53, EGFr, Mitotic Index and Papillary Status in Primary Superficial (Stage pTa/T1) Bladder Cancer: A Prospective Comparative Study. European Urology. 36(5). 393–400. 80 indexed citations
18.
19.
20.
Hellsten, Sverker, et al.. (1998). Nordic Prospective Trials of Radical Cystectomy and Neoadjuvant Chemotherapy. European Urology. 33(Suppl. 4). 35–38. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Solsona Breakdown of academic impact, for papers by A. Masson-Lecomte Breakdown of academic impact, for papers by Daniel Willis Breakdown of academic impact, for papers by Daniele Raggi Breakdown of academic impact, for papers by José L. Domínguez-Escrig Breakdown of academic impact, for papers by Christine de Balincourt Breakdown of academic impact, for papers by Michael P. Corder Breakdown of academic impact, for papers by LaMont Barlow Breakdown of academic impact, for papers by Begoña P. Valderrama Breakdown of academic impact, for papers by Peter Jenkins
Rankless by CCL
2026